Artificial Intelligence (AI) in Medical Imaging Market: Growth, Size, Share, and Trends

Report Code HIT 9238
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Artificial Intelligence (AI) in Medical Imaging Market by Component(Hardware, Software, Service), Modality (MRI, CT, X-Ray), Application (Radiology, Cardio, Cancer- Lung, Breast, Prostate), End User(Hospital, Imaging Center) - Global Forecast to 2029

Overview

The global AI medical imaging market, valued at US$1.29 billion in 2023, is forecasted to grow at a robust CAGR of 22.4%, reaching US$1.65 billion in 2024 and an impressive US$4.54 billion by 2029. The factors driving the market growth include increasing government initiatives on AI-based technologies, higher funding for AI startups, a massive inflow of big data, and growing cross-industry collaborations. The market offers significant opportunities, particularly in untapped emerging markets such as Latin America, Southeast Asia, and Africa, where expanding healthcare infrastructure creates demand for cost-effective, AI-powered diagnostic solutions. Furthermore, a focus on developing human-aware AI systems that align with clinician decision-making and provide interpretable, patient-centered insights is immense to foster trust and adoption in medical settings. AI's capability to enhance early detection, automate imaging workflows, and integrate with advanced imaging modalities positions it as a transformative force in improving diagnostic accuracy and healthcare outcomes globally.

AI in Medical Imaging Market

Attractive Opportunities in the AI in Medical Imaging Market

North America

Factors such as the shortage of radiologists, the increasing prevalence of chronic diseases, ongoing research into AI-based imaging tools, and substantial funding for R&D in AI-driven diagnostic solutions are key drivers of the regional market.

The rising demand for AI tools, an increased focus on reducing the workload of radiologists, an influx of large and complex datasets, funding for AI-based startups, and cross-industry collaborations propel market expansion worldwide.

Emerging markets and increasing efforts to develop human-aware AI systems present significant growth opportunities, particularly in the Asia Pacific and Latin American markets.

The European AI in medical imaging market is projected to reach USD 1.54 billion by 2029, growing at an impressive CAGR of 21.2% during the forecast period, due to advancements in AI integration.

Reluctance to adopt AI technologies, budgetary constraints, unstructured healthcare data, data privacy concerns, and limited interoperability pose challenges to market growth.

Global AI in Medical Imaging Market Dynamics

DRIVER: Increasing Growing demand for AI-based solutions to reduce work pressure on radiologists

The medical imaging industry has rapidly embraced AI technologies due to their transformative potential, revolutionizing imaging processes and improving clinical outcomes. AI automates routine tasks and enables radiologists to focus more on improved patient care. The rising shortage of radiologists drives the increasing demand for AI-based solutions in radiology; the estimates indicate that there has been a need for almost 42,000 additional radiologists in the US by 2033. AI-powered tools improve the accuracy of diagnosis, automate workflow, and reduce the workload of radiologists by efficiently interpreting massive volumes of diagnostic data. Partnerships with major players such as Microsoft, Bayer, Google Cloud, and Qure.ai help enhance AI algorithms, increase operational efficiency, and streamline clinical workflows. These partnerships help improve the quality of AI solutions used for medical imaging technologies. Moreover, cloud-based platforms, such as IBM's Imaging AI Orchestrator, provide scalable access to regulatory-cleared AI solutions to help radiologists manage their diagnostic insights effectively. Countries have made favorable regulations to include imaging solutions in their medical sector, improving the overall diagnostic industry. All these highlight the role of AI in tackling workforce challenges and enhancing imaging outcomes.

RESTRAINT: Inadequate AI workforce and ambiguous regulatory guidelines for medical software

The deployment of AI in healthcare faces significant challenges due to a scarcity of competent experts and ambiguous regulations. Creating and integrating AI systems in healthcare settings necessitates skills in advanced domains such as cognitive computing, ML, deep learning, and image analysis. The complexity of these technologies necessitates precise data processing to imitate human brain operations, and even tiny errors might result in failures or undesirable effects. However, the lack of skilled specialists and standardized AI credentials impedes growth, which hampers the sector's overall development. Furthermore, the regulation of medical AI software is inconsistent and imprecise. Rapid advances in AI technology make it challenging for regulators to develop and maintain current norms. AI solutions in healthcare must fulfill high criteria for accuracy, dependability, and clinical safety. Still, fragmented and changing rules in different regions create confusion. Various interpretations by governing authorities exacerbate the delay in the deployment and adoption of AI-based solutions. A strong workforce development strategy, the implementation of global standards, and unambiguous regulatory frameworks are required to solve these difficulties and realize AI's full potential for improving healthcare diagnostics and patient care.

 

OPPORTUNITY: Growth opportunities in untapped emerging markets

The growing patient population and developing healthcare infrastructure in emerging nations such as China, India, and Brazil present substantial growth prospects for AI-based medical imaging. For example, the NIH and Family Welfare in India estimates that there are between 2 and 2.5 million cancer patients at any given time, with about 700,000 new cases recorded each year. Similarly, the healthcare industries in emerging economies such as China and India have evolved quickly due to the uptake of cutting-edge medical technology, especially in sophisticated imaging equipment. Medical imaging data is increasing due to this expansion, opening up new possibilities for AI-driven imaging.

Leading businesses have entered these areas to take advantage of this potential. To promote early diagnosis and care of breast cancer, NIRAMAI collaborated with the Punjab Government and Roche Pharma India in 2022 to improve breast cancer screening utilizing Thermalytix, an AI-powered diagnostic engine. Similarly, Intel Corporation established an AI research center in Hyderabad, India, in 2020 to capitalize on the expanding Indian market. The same year, Siemens Healthineers declared it would invest EUR 160 million over the following five years to create an innovation hub in Bengaluru, India. The enormous expansion potential of AI medical imaging in emerging markets is reflected in these endeavors.

CHALLENGES: Reluctance to embrace AI-based technologies among physicians

With AI technology providing tools that improve diagnosis and patient care, the quick development of digital health allowed healthcare practitioners to embrace novel treatment modalities. Still, there is a noticeable hesitancy among physicians to adopt these developments. Many medical professionals believe that human traits such as empathy and persuasion cannot be recreated by technology, which leads them to assume that AI will eventually replace doctors. Long-term doctor-patient interactions may be strained if patients grow unduly dependent on AI tools and perhaps neglect essential in-person sessions. Furthermore, medical experts doubt AI systems' ability to identify illnesses accurately. For example, surgical robots still need human supervision to notice vital behavioral signs that can avert difficulties, even though they are excellent at logical tasks. Even while AI-based solutions can enhance patient care and make doctors' lives more convenient, these uncertainties make it difficult to persuade providers of their cost-effectiveness, efficiency, and sustainability. However, healthcare professionals have started to see the advantages of AI technologies. There is a good chance that physicians and radiologists will be more likely to use AI-based tools in healthcare in the years to come as trust in these solutions increases.

Global AI in Medical Imaging Market Ecosystem Analysis

The Al ecosystem in the medical imaging market involves various stakeholders, technologies, and trends that contribute to the development and application of Al solutions. Key stakeholders include network, connectivity, and hardware providers; infrastructure service providers; Al software and service providers; healthcare providers and diagnostics centers; government and regulatory bodies; research centers and academic & government institutes; and start-ups.

AI in Medical Imaging Market
 

Software to command the largest market share, by component, in 2023.

On the basis of components, the global AI in medical imaging market is segmented into software, services, and hardware. In 2023, the software segment commanded the largest market share due to its function as an application with advanced data processing algorithms and diagnostic support. High accuracy, scalability, and customized solutions make AI-driven software systems integral to pathology, genomics, and medical imaging. Such systems are widely employed for work such as workflow optimization, the prediction of diseases, and cancerous formation detection. For example, an algorithm known as deep learning proved effective within AI software applications in diagnosing carcinomas at higher than 90%. This technology can detect cancerous tumors and tissues without human errors, leading to better disease diagnosis and treatment. The expansion of this market has also been fuelled by the growing application of AI in imaging systems, specifically for activities such as tumor detection, neurological problem diagnosis, and process optimization; these help medical practitioners ensure advanced treatment options. Furthermore, real-time picture analysis and sharing are made possible by developments in cloud-based systems and seamless integration capabilities, which enhance provider collaboration.

Hospitals accounted for largest share of the AI in medical imaging end user market in 2023.

On the basis of end users, the market is segmented into hospitals, diagnostic imaging centers, and other end users. In 2023, hospitals hold the largest market share due to sophisticated IT infrastructure, simple access to vast patient data, and the expanding application of AI technologies in healthcare settings. This end user segment has gained from AI's capacity to improve diagnostic precision and expedite decision-making since these are the primary healthcare providers for the most challenging patients. AI technology can analyze large amounts of medical imaging data, improve patient outcomes, and speed up diagnosis, especially in difficult cases such as cancer, neurological problems, and heart ailments. Hospitals have increasingly adopted AI tools to improve workflow efficiencies, reduce human errors, and optimize resource utilization. For instance, AI-driven imaging systems can accurately identify abnormalities in radiographs and CT scans, enabling faster treatments and interventions. AI's ability to integrate with hospital IT systems also supports real-time monitoring and decision-making, contributing to better clinical outcomes. As a result, hospitals are expected to continue to lead the market, driving growth in AI adoption for medical imaging across the healthcare industry.

North America held the largest market share in 2023.

In 2023, North America accounted for the largest share of the global AI in medical imaging market. The shortage of radiologists in the region has created a huge demand for AI-based imaging tools that can assist or even replace human radiologists in tasks such as the interpretation of medical images. AI solutions can significantly improve efficiency, reduce the workload on healthcare professionals, and help bridge this gap. The region has also experienced an increase in chronic diseases, further fueling the demand for advanced diagnostic tools to improve patient outcomes. A strong research environment in North America, along with increased funding for studies regarding the ethical utilization of AI in imaging tools, also propels the use of AI in healthcare activities. There has been a development and a very high level of investment in the health infrastructure of this region, coupled with a high amount of investment in AI-driven technology that supports the rapid acceleration of AI solutions in the field of medical imaging. These factors collectively contribute to North America's dominant position in the global AI in medical imaging market.

HIGHEST CAGR MARKET IN 2024-2029
US FASTEST GROWING MARKET IN THE REGION
AI in Medical Imaging Market

Recent Developments of AI in Medical Imaging Market

  • Partnership: In July 2024, Microsoft partnered with Mass General Brigham and the University of Wisconsin to enhance AI models for medical imaging, improving radiologist efficiency and patient outcomes.
  • Collaboration: In March 2024, Microsoft (US) collaborated with NVIDIA(US) to combine Azure’s cloud and AI capabilities with NVIDIA’s DGX cloud and Clara suite to accelerate innovations in medical imaging, diagnosis, and patient care
  • Collaboration: In July 2024, GE Healthcare collaborated with AWS to create AI-driven healthcare models, optimizing workflows and boosting diagnostic accuracy.
  • Partnership: In November 2023, NVIDIA Corporation (US) partnered with the National Health Research Institute (Taiwan) to leverage accelerated computing and AI for advancing biomedical research by adopting NVIDI’s powerful Blackwell platform, which enables complex data analysis and supports applications ranging from medical imaging to drug discovery and personalized medicine.

Key Market Players

KEY PLAYERS IN THE AI IN MEDICAL IMAGING MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Artificial Intelligence (AI) in Medical Imaging Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/Billion)
Segments covered Component, Application, End User, And Region
Geographies covered North America (US, and Canada), Europe (Germany, France, UK, Italy, Spain and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), Middle East & Africa (GCC Countries and RoMEA).

 

Key Questions Addressed by the Report

What is the projected market of the global AI in medical imaging market in 2029?
The AI in medical imaging market is projected to reach USD 4.54 billion by 2029.
Who are the leading players in the AI in medical imaging Market?
Some of the prominent players operating in the market are Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Imaging Inc. (US), Advanced Micro Devices, Inc. (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc. (US), icometrix (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc. (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), Brainomix (UK).
What are the major components of the AI in medical imaging market?
Software, hardware, and services are major components of the global AI in the medical imaging market. In 2023, the software segment accounted for the largest share of the AI in medical imaging market.
What are the applications of the AI in medical imaging Market?
Out of radiology, oncology, neurology, cardiology, OB/GYN, and ophthalmology applications in AI in medical imaging, the radiology segment commanded the largest share of this market in 2023
What are the key end users in the AI in medical imaging Market?
Out of the major end users, the AI in the medical imaging market, such as hospitals, diagnostic imaging centers, and other end users, the hospitals segment accounted for the largest market share in 2023.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence (AI) in Medical Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
16
EXECUTIVE SUMMARY
67
PREMIUM INSIGHTS
80
MARKET OVERVIEW
116
  • 5.1 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    KEY GROWTH OPPORTUNITIES
    INDUSTRY-SPECIFIC CHALLENGES
  • 5.2 PORTER’S FIVE FORCES ANALYSIS
  • 5.3 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
    REGULATORY FRAMEWORK
  • 5.4 ECOSYSTEM MARKET MAP
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
  • 5.8 PATENT ANALYSIS
  • 5.9 PRICING ANALYSIS
    INDICATIVE PRICING ANALYSIS OF COMPONENT, 2023
    INDICATIVE PRICING ANALYSIS OF COMPONENT, BY KEY PLAYERS, 2023
    INDICATIVE PRICING ANALYSIS, BY REGION, 2023
  • 5.10 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - MACHINE LEARNING ALGORITHMS
    - DEEP LEARNING
    - COMPUTER VISION
    COMPLIMENTARY TECHNOLOGIES
    - LABORATORY AUTOMATION
    - ELECTRONIC HEALTH RECORDS (EHR)
    ADJACENT TECHNOLOGIES
    - NATURAL LANGUAGE PROCESSING (NLP)
    - BIG DATA ANALYTICS
  • 5.11 KEY CONFERENCES & EVENTS IN 2024-2025
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN THE BUYING PROCESS
    BUYING CRITERIA
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 UNMET NEEDS/END USER EXPECTATIONS IN AI IN MEDICAL IMAGING MARKET
  • 5.16 ADJACENT MARKET ANALYSIS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 REIMBURSEMENT SCENARIO
AI IN MEDICAL IMAGING MARKET, BY COMPONENT (USD MILLION; 2022-2029)
156
  • 6.1 INTRODUCTION
  • 6.2 SOFTWARE
  • 6.3 HARDWARE
    PROCESSORS
    - MICROPROCESSOR UNITS
    - GRAPHICS PROCESSING UNITS
    - FIELD PROGRAMMABLE GATE ARRAYS
    - APPLICATION-SPECIFIC INTEGRATED CIRCUIT
    MEMORY
    NETWORKS
    - ADAPTERS
    - SWITCHES
    - INTERCONNECTS
  • 6.4 SERVICES
AI IN MEDICAL IMAGING MARKET, BY APPLICATION (USD MILLION; 2022-2029)
199
  • 7.1 INTRODUCTION
  • 7.2 RADIOLOGY
  • 7.3 CARDIOLOGY
  • 7.4 ONCOLOGY
    BREAST CANCER
    LUNG CANCER
    PROSTATE CANCER
    COLORECTAL CANCER
    OTHER CANCERS
  • 7.5 NEUROLOGY
  • 7.6 OPHTHALMOLOGY
  • 7.7 OBSTETRICS & GYNECOLOGY
  • 7.8 OTHER APPLICATIONS
AI IN MEDICAL IMAGING MARKET, BY MODALITY (USD MILLION; 2022-2029)
220
  • 8.1 INTRODUCTION
  • 8.2 CT
  • 8.3 MRI
  • 8.4 X-RAY
  • 8.5 ULTRASOUND
  • 8.6 MAMMOGRAPHY
  • 8.7 OTHER IMAGING MODALITIES
AI IN MEDICAL IMAGING MARKET, BY END USERS (USD MILLION; 2022-2029)
292
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & SURGICAL CENTERS
  • 9.3 DIAGNOSTIC IMAGING CENTERS
  • 9.4 OTHER END USERS
AI IN MEDICAL IMAGING MARKET, BY REGION (USD MILLION; 2022-2029)
302
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    CANADA
  • 10.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    UK
    FRANCE
    ITALY
    SPAIN
    REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    ASIA-PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    JAPAN
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA-PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST AND AFRICA: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPES
388
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2024)
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS BY KEY PLAYERS 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - COMPONENT FOOTPRINT
    - APPLICATION FOOTPRINT
    - MODALITY FOOTPRINT
    - END-USER FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES,2023
    - DETAILED LIST OF KEY STARTUPS/SMES
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 COMPETITIVE SITUATION AND TRENDS (2021-2024)
    NEW PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.9 R&D ASSESSMENT OF KEY PLAYERS
  • 11.10 COMPANY VALUATION AND FINANCIAL METRICS
COMPANY PROFILES
407
  • 12.1 KEY PLAYERS
    MICROSOFT
    NVIDIA
    MERATIVE
    GOOGLE
    INTEL CORPORATION
    SIEMENS HEALTHINESS
    KONINKLIJKE PHILIPS N.V
    GE HEALTHCARE
    ADVANCED MICRO DEVICES INC
    DIGITAL DIAGNOSTICS INC
    INFORM AI
    AIDOC
    FUJIFILM
    VUNO INC
    NEURAL ANALYTICS (NOVASIGNAL CORPORATION)
    RIVERAIN TECHNOLOGIES
    ZEBRA MEDICAL VISION, INC
    IMAGEN TECHNOLOGIES
    HEARTFLOW
    RETINA AI
  • 12.2 OTHER PLAYERS
    ENLITIC, INC
    CELLMATIQ
    BUTTERFLY NETWORK INC
    NANO-X IMAGING LTD.
    VIZ AI INC.
    PAIGE AI
    QURE AI
    LUNIT INC.
    BRAINOMIX
    SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD
APPENDIX
456

The scope for a well-balanced approach for both primary and secondary research about the AI in medical imaging market involved the review of many relevant variables for the small, medium-sized, and large enterprises. Direct engagement with experts from all across the industry value chain would take place, validating assumptions and findings during primary research for market size. This estimate was produced using a mix of several methodologies including a top-down and bottom-up approach. It studied significant market segments, evolving trends, regulatory frameworks, and competitive landscapes. It also considered market leaders and their strategies. Data triangulation was used at the end to finalize market size estimates, and primary research was used to validate the hypotheses.

Secondary Research

Secondary research relied on information derived from reputable sources, such as government publications, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva. These sources provided critical data on the technical, market-oriented, and commercial aspects of the AI in medical imaging market. Secondary data was analyzed to estimate the size of the market, and its accuracy was cross-checked through primary research.

Primary Research

Based on insights drawn from secondary sources, primary research was conducted to better understand the global AI in medical imaging market. Interviews were conducted with market participants from demand-side stakeholders such as hospitals, clinics, diagnostic laboratories, and imaging centers, as well as from supply-side participants including executives, product managers, marketing and sales managers from manufacturers, distributors, and channel partners. These interactions cut across key regions, including North America, Europe, Asia Pacific, and the Rest of the World. About 70% of the interviews involved supply-side experts, while 30% included demand-side participants. Data was collected through a combination of surveys, questionnaires, email correspondence, and telephonic and in-person interviews.

AI in Medical Imaging Market

Note 1: C-level primaries include CEOs, CFOs, and COOs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size of the global AI in medical imaging market was estimated based on a review of prominent companies and their revenue shares. Key players, who hold significant shares of the market, were identified through secondary research, and their respective revenue figures were calculated. The process involved analyzing the annual and financial reports of major market participants as part of secondary research. Additionally, in-depth interviews with key industry leaders, such as directors, CEOs, and marketing executives, were conducted as part of primary research.

Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical imaging market and its associated submarkets. The research methodology used includes the following details:

  • Revenues of individual companies were gathered from public sources and databases.
  • Shares of the AI in medical imaging market players were gathered from secondary sources to the extent available. In certain cases, these shares were determined through a detailed analysis of parameters such as product portfolios, market positioning, pricing strategies, and geographic reach.
  • Individual shares or revenue estimates were validated through expert interviews.
  • Percentage shares, splits, and breakdowns for the global AI in medical imaging market were determined by secondary sources and verified through primary research.
  • All macroeconomic indicators influencing market revenue growth were extensively analyzed and validated through primary research, ensuring that both qualitative and quantitative data were accurately verified.
AI in Medical Imaging Market

Data Triangulation

The market size estimation of the overall market for AI in the medical imaging market followed a comprehensive market size estimation process. This process segmented the market into various segments and subsegments for better analysis. Data triangulation and market breakdown methodologies were used wherever applicable to ensure accuracy. This process included the assessment of various factors and trends from both demand and supply sides, which could help provide reliable and in-depth insights into the market. The AI in medical imaging market encompasses the use of artificial intelligence technologies to enhance, analyze, and interpret medical images in areas like radiology, oncology, cardiology, and other medical specialties, thereby enhancing diagnostic accuracy and patient care.

Market Definition

Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.

AI is used in the medical imaging market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose conditions.

Stakeholders

  • Hospitals
  • Diagnostic care centers
  • Diagnostic laboratories
  • Radiologists and radiology clinics
  • Diagnostic imaging AI device manufacturers and suppliers
  • Medical research laboratories
  • Academic medical centers and universities

Report Objectives

  • To define, describe, and forecast artificial intelligence in the medical imaging market based on component, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches/enhancements, expansions, agreements, collaborations, partnerships, and approvals in AI medical imaging market

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Artificial Intelligence (AI) in Medical Imaging Market

DMCA.com Protection Status